Advertisement
Canada markets close in 2 hours 2 minutes
  • S&P/TSX

    21,974.21
    +88.83 (+0.41%)
     
  • S&P 500

    5,110.61
    +62.19 (+1.23%)
     
  • DOW

    38,313.55
    +227.75 (+0.60%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.88
    +0.31 (+0.37%)
     
  • Bitcoin CAD

    87,441.39
    -948.58 (-1.07%)
     
  • CMC Crypto 200

    1,328.25
    -68.28 (-4.89%)
     
  • GOLD FUTURES

    2,350.80
    +8.30 (+0.35%)
     
  • RUSSELL 2000

    2,003.19
    +22.07 (+1.11%)
     
  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     
  • NASDAQ

    15,958.18
    +346.42 (+2.22%)
     
  • VOLATILITY

    15.12
    -0.25 (-1.63%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     

Amgen’s Pipeline Could Boost Its Long-Term Growth Opportunities

EVENITY (romosozumab) is a monoclonal antibody under investigation that acts by inhibiting the activity of sclerostin.